Patents by Inventor Bernt Pragl

Bernt Pragl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable aqueous formulation for growth hormone
    Patent number: 11446381
    Abstract: The present invention is related to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ?0.7 and ?5.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: September 20, 2022
    Assignee: SANDOZ AG
    Inventors: Bernt Pragl, Sabine Fuertinger
  • STABLE AQUEOUS FORMULATION FOR GROWTH HORMONE
    Publication number: 20180256722
    Abstract: The present invention is related to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ?0.7 and ?5.
    Type: Application
    Filed: March 6, 2018
    Publication date: September 13, 2018
    Inventors: Bernt Pragl, Sabine Fuertinger
  • Pharmaceutical formulation comprising a biopharmaceutical drug
    Patent number: 9480743
    Abstract: The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug, said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2-6 C-Atoms, or at least one salt thereof.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: November 1, 2016
    Assignee: Hexal AG
    Inventors: Martina Danek-Bulius, Britta Deutel, Sabine Fürtinger, Bernt Pragl, Drago Kuzman
  • AQUEOUS FORMULATION COMPRISING AT LEAST A NEUTRAL SALT AND A BIOPHARMACEUTICAL PROTEIN
    Publication number: 20140194356
    Abstract: The present invention is related to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ?0.7 and ?5.
    Type: Application
    Filed: July 25, 2012
    Publication date: July 10, 2014
    Applicant: SANDOZ AG
    Inventors: Bernt Pragl, Sabine Fuertinger
  • PHARMACEUTICAL FORMULATION COMPRISING A BIOPHARMACEUTICAL DRUG
    Publication number: 20130336968
    Abstract: The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug, said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2-6 C-Atoms, or at least one salt thereof.
    Type: Application
    Filed: December 28, 2011
    Publication date: December 19, 2013
    Applicant: HEXAL AG
    Inventors: Martina Danek-Bulius, Britta Deutel, Sabine Furtinger, Bernt Pragl, Drago Kuzman